Why GLP-1?

Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Trusted brands in one place

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Generic Ozempic Is Coming — Just Not for Americans
News & Updates

Generic Ozempic Is Coming — Just Not for Americans

Generic versions of semaglutide (the active ingredient in Ozempic) are becoming available in several countries, but U.S. patients face a longer wait due to patent protections. Here is what that means for your wallet, your treatment options, and what you can realistically do today.

Read More
FDA Leadership Change: What It Means for GLP-1s
News & Updates

FDA Leadership Change: What It Means for GLP-1s

FDA Commissioner Marty Makary is stepping down, with Kyle Diamantas stepping in as acting commissioner. For patients on GLP-1 medications like semaglutide or tirzepatide, this kind of transition raises real questions about drug approvals, compounding policy, and access. Here's what you actually need to know.

Read More
How GLP-1s Are Changing Diabetes Care
GLP-1 Agonists

How GLP-1s Are Changing Diabetes Care

GLP-1 medications like semaglutide and tirzepatide are doing far more than helping people lose weight. They are fundamentally changing how diabetes is treated and how pharmacists and providers work together to care for patients. Here is what that shift means for you.

Read More
High-Dose Wegovy: Near 28% Weight Loss Results
Weight Loss

High-Dose Wegovy: Near 28% Weight Loss Results

New clinical trial data from Novo Nordisk shows a higher dose of semaglutide (Wegovy) may produce nearly 28% body weight loss in early responders. Here is what that means for patients currently on GLP-1 therapy, those considering it, and how this could shape treatment decisions going forward.

Read More
GLP-1 Drugs and Breast Cancer: What We Know
Side Effects & Safety

GLP-1 Drugs and Breast Cancer: What We Know

Emerging research is exploring whether GLP-1 medications like semaglutide and tirzepatide could improve survival outcomes in breast cancer patients. Scientists believe the connection runs through obesity, inflammation, and insulin signaling. Here's what the early evidence shows and what it means for patients today.

Read More
Wegovy Pill: 21.6% Weight Loss in Early Data
News & Updates

Wegovy Pill: 21.6% Weight Loss in Early Data

Novo Nordisk presented early data on an oral version of Wegovy at ECO2026, showing 21.6% weight loss in early responders and doubled improvements in mobility. Here's what the findings mean for patients weighing their GLP-1 options.

Read More
GLP-1 Drugs: Unexpected Benefits and Risks
Side Effects & Safety

GLP-1 Drugs: Unexpected Benefits and Risks

GLP-1 medications like semaglutide and tirzepatide are turning up benefits that go well beyond weight loss, from heart protection to addiction suppression. But they also carry risks that deserve an honest look. This guide covers both sides so you can have a fully informed conversation with your doctor.

Read More
Generic Ozempic Coming to Canada: What to Know
News & Updates

Generic Ozempic Coming to Canada: What to Know

Dr. Reddy's is set to launch a generic version of semaglutide (the active ingredient in Ozempic) in Canada within days. This is a significant development for patients seeking more affordable GLP-1 access. Here's what it means for you, whether you're in Canada or watching for similar changes in the U.S.

Read More
BALANCE Model & Medicare GLP-1 Coverage Explained
News & Updates

BALANCE Model & Medicare GLP-1 Coverage Explained

The BALANCE Model is a federal initiative designed to expand GLP-1 medication access for Medicare and Medicaid patients with obesity. Paired with the Medicare GLP-1 Bridge program, it could significantly reduce out-of-pocket costs for millions of Americans. Here is what you need to know about eligibility, timing, and what to ask your doctor.

Read More